EP4347654 - T CELL ENGAGER MOLECULES AND USES THEREOF [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 08.03.2024 Database last updated on 03.09.2024 | |
Former | The international publication has been made Status updated on 09.12.2022 | ||
Former | unknown Status updated on 08.07.2022 | Most recent event Tooltip | 08.08.2024 | Change: Validation states | published on 11.09.2024 [2024/37] | 08.08.2024 | Change - extension states | published on 11.09.2024 [2024/37] | Applicant(s) | For all designated states Amgen Research (Munich) GmbH Staffelseestrasse 2 81477 München / DE | For all designated states Amgen Inc. One Amgen Center Drive Thousand Oaks, California 91320 / US | [2024/15] | Inventor(s) | 01 /
BROZY, Johannes 81477 Munich / DE | 02 /
DAHLHOFF, Christoph 81477 Munich / DE | 03 /
RAUM, Tobias 81477 Munich / DE | 04 /
PENDZIALEK, Jochen, S. 81477 Munich / DE | 05 /
WINKEL, Lisa 81477 Munich / DE | 06 /
MUENZ, Markus 81477 Munich / DE | 07 /
PIERCE, Nathan, William Thousand Oaks, California 91320-1799 / US | 08 /
KIELCZEWSKA, Agnieszka Thousand Oaks, California 91320-1799 / US | 09 /
CHEN, Wentao Thousand Oaks, California 91320-1799 / US | 10 /
BATES, Darren, L. Thousand Oaks, California 91320-1799 / US | 11 /
BLUEMEL, Claudia 81477 Munich / DE | 12 /
HONER, Jonas, Karl-Josef 81477 Munich / DE | [2024/15] | Representative(s) | Lau, Sarah Jane, et al Kilburn & Strode LLP Lacon London 84 Theobalds Road London WC1X 8NL / GB | [2024/15] | Application number, filing date | 22734448.8 | 02.06.2022 | [2024/15] | WO2022US32006 | Priority number, date | US202163197265P | 04.06.2021 Original published format: US 202163197265 P | US202163236547P | 24.08.2021 Original published format: US 202163236547 P | [2024/15] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2022256559 | Date: | 08.12.2022 | Language: | EN | [2022/49] | Type: | A1 Application with search report | No.: | EP4347654 | Date: | 10.04.2024 | Language: | EN | The application published by WIPO in one of the EPO official languages on 08.12.2022 takes the place of the publication of the European patent application. | [2024/15] | Search report(s) | International search report - published on: | EP | 08.12.2022 | Classification | IPC: | C07K16/28, C07K16/30, A61P35/00 | [2024/15] | CPC: |
C07K16/28 (EP,IL);
C07K16/2866 (EP,IL,KR);
A61P35/00 (EP,IL,KR);
C07K16/2803 (EP,IL);
C07K16/2809 (EP,IL,KR);
C07K16/2818 (KR);
C07K16/2827 (KR);
C07K16/2887 (EP,IL);
C07K16/30 (EP,IL);
A61K2039/505 (KR);
C07K2317/31 (EP,IL,KR);
C07K2317/33 (EP,IL,KR);
C07K2317/34 (EP,IL);
C07K2317/52 (EP,IL);
C07K2317/55 (EP,IL,KR);
C07K2317/622 (EP,IL,KR);
C07K2317/73 (EP,IL);
C07K2317/732 (KR);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2024/15] | Title | German: | T-ZELL-ENGAGER-MOLEKÜLE UND VERWENDUNGEN DAVON | [2024/15] | English: | T CELL ENGAGER MOLECULES AND USES THEREOF | [2024/15] | French: | MOLÉCULES DE RECRUTEURS DE LYMPHOCYTES T ET LEURS UTILISATIONS | [2024/15] | Entry into regional phase | 28.11.2023 | National basic fee paid | 28.11.2023 | Designation fee(s) paid | 28.11.2023 | Examination fee paid | Examination procedure | 28.11.2023 | Examination requested [2024/15] | 28.11.2023 | Date on which the examining division has become responsible | 09.07.2024 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 19.06.2024 | Renewal fee patent year 03 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]WO2016077638 (SLOAN KETTERING INST CANCER [US]); | [XYI]WO2018072025 (GOVERNING COUNCIL UNIV TORONTO [CA], et al); | [Y]CN110835371 (PUMISI BIO TECH SUZHOU CO LTD); | [A]WO2020138489 (SHIONOGI & CO [JP], et al); | by applicant | US6210924 | WO2019140196 |